Clinical Trial Update: Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel [Phase 3]

View source ↗

Summary

Phase 3 study of COL-1620 vaginal progesterone gel for luteal phase support in IVF with embryo transfer has completed and results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• COL-1620 Vaginal Progesterone Gel (progesterone vaginal gel)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Luteal Hormone Supplementation in In-vitro Fertilization, Embryo Transfer | Phase 3 | Status: COMPLETED | Results posted: 2015-12-21